跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,584 条关于
“Symrise AG”
全部
1,584
临床试验
376
药物
376
机构
289
资讯
543
去年
Symrise Partners with HBC to Expand Marine-Based Health Ingredients Portfolio
11个月前
Symrise Invests in Cellibre to Advance Precision Fermentation Technology for Flavor and Cosmetic Ingredients
去年
Fabhalta Demonstrates Sustained Efficacy in Phase III C3 Glomerulopathy Trial
去年
Formycon's Aflibercept Biosimilar, AHZANTIVE®/Baiama®, Receives Positive CHMP Opinion for EU Approval
2年前
4SC AG Receives MHRA Waiver for Resminostat in Pediatric CTCL
3年前
4SC's Resminostat Advances Towards European Market Approval for CTCL Maintenance Therapy
4年前
RESMAIN Study: Resminostat Shows Promise in Cutaneous T-Cell Lymphoma Maintenance
6年前
RESMAIN Trial of Resminostat for CTCL Maintenance Continues After Positive Safety Review
4个月前
908 Devices Acquires NIRLAB AG to Strengthen Narcotics Detection Capabilities
去年
Memo Therapeutics Completes Enrollment in Phase II Trial of Potravitug for BK Viremia
第 1 页,共 55 页
上一页
下一页